Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2022-10-20 00:00:00 ET · period of report 2022-10-20 · accession 0001415889-22-010738 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-20 | 2022-10-20 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $1.05 | +4,762 | 32.4K | +17% | +$5,000 | |
| 2022-10-20 | 2022-10-20 | FENC | RALLIS CHRIS A | Dir | F - Tax | $8.26 | -2,068 | 30.4K | -6% | -$17.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-10-20 | M | A | 4,762 | $1.05 | 32,419 | D | — | — | (F1) Represents options granted on November 11, 2012, with a $1.05 USD strike price and an expiration of November 11, 2022. |
| 2 | Common | Common Shares | 2022-10-20 | F | D | 2,068 | $8.26 | 30,351 | D | — | — | (F2) Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,762 shares from an November 11, 2012 grant. |